Phoenix, AZ
Chelation Therapy clinics in Phoenix
Chelation therapy in Phoenix is offered by a small set of integrative and naturopathic clinics, typically for documented heavy metal toxicity confirmed by provocation or baseline testing. Common agents include calcium disodium EDTA, DMPS, DMSA, and deferoxamine, each with specific binding profiles for lead, mercury, arsenic, or iron.
Most Phoenix chelation providers are MDs or DOs with ACAM training, and in some states naturopathic doctors within their licensed scope. Protocols vary from 10-session courses for basic detoxification to longer 30-session cardiovascular protocols modeled on the TACT trial. Pricing is cash-pay in almost every case, and no insurance covers off-label chelation.
With verified chelation therapy clinics on Regenerated.com in Phoenix, Arizona, patients can compare provider credentials, testing protocols, and agent selection. Regenerated.com does not recommend chelation for cardiovascular disease or autism. The FDA has only approved specific agents for specific heavy metal poisoning diagnoses. Chelation outside that narrow indication is off-label, and in the wrong hands it has caused deaths.
Peace Wellness Center
- Vitamin IV Therapy
- PRP Therapy
- IV Therapy
- Arthritis Treatment
- Chelation Therapy
Living Wellness Medical Center
- IV Therapy
- Chelation Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
Naturopathic Clinic
- IV Therapy
- IV Hydration
- Chelation Therapy
- Peptide Therapy
- Hormone Replacement Therapy (HRT)
Regulatory context
A note on Arizona's chelation therapy rules.
The FDA has approved a narrow set of chelating agents for specific heavy metal toxicities. Calcium disodium edetate (CaNa2EDTA, Versenate) is approved for symptomatic lead poisoning, succimer (Chemet, DMSA) for pediatric lead poisoning at blood lead levels above 45 mcg/dL, deferoxamine (Desferal) and deferasirox (Exjade) for chronic iron overload, and dimercaprol (BAL) for arsenic, gold, and acute lead poisoning. Use of EDTA chelation for cardiovascular disease was studied in the NIH-funded TACT trial (2013) with controversial findings and remains not FDA-approved for that indication. Chelation for autism spectrum disorder is not evidence-based and has been linked to pediatric deaths. The FDA issued a 2010 sweep of warning letters to compounders marketing OTC chelation products with unapproved disease claims.
-
Arizona Naturopathic Physicians Medical Board, A.R.S. Title 32, Chapter 14
Licensed naturopathic physicians in Arizona may administer chelation therapy within their defined scope of practice. -
Arizona Medical Board, A.R.S. Title 32, Chapter 13
MDs may use chelation off-label under standard physician practice but face board scrutiny for unsupported claims.
The Arizona Medical Board and Naturopathic Physicians Medical Board have investigated practitioners for chelation marketing tied to autism, cardiovascular disease, and chronic fatigue. Arizona has a sizable integrative medicine sector and a higher concentration of NDs administering IV chelation than most states. Enforcement actions have focused on misleading advertising and lack of informed consent rather than blanket prohibitions. The 2005 Pittsburgh pediatric death from a Na2EDTA infusion (wrong agent administered) shifted national board attention toward administration safety protocols.